Document is current
Any future updates will be listed below
-
Authors
Fumagalli, Valeria
Iannacone, Matteo https://orcid.org/0000-0002-9370-2671
- License Information
-
More Information
Article History
First Online: 18 November 2024
Competing interests
: M.I. participates in advisory boards, consults for or receives funding from Gilead Sciences, Asher Biotherapeutics, GentiBio, BlueJay Therapeutics, Aligos Therapeutics, HumAbs Biomed/VIR Biotechnology, BioNTech, Excision BioTherapeutics and Moderna. V.F. declares no competing interests.
